Atrovent Inhaler (Ipratropium)

(℞) Prescription Required

Top Brand Choice
Top Generic Choice

Atrovent Inhaler 20mcg

Product of United Kingdom
Manufactured by: Boehringer Ingelheim
*Product image for reference use only.
Select Quantity
Atrovent Inhaler 20mcg
Product of United Kingdom
Manufactured by Boehringer Ingelheim
Top Brand Choice
Top Generic Choice

Ipratropium Bromide Inhaler 20mcg

Product of United Kingdom
Manufactured by: UK Various Generics
*Product image for reference use only.
Select Quantity
Ipratropium Bromide Inhaler 20mcg
Product of United Kingdom
Manufactured by UK Various Generics
Top Brand Choice
Top Generic Choice

Atrovent Inhaler 20mcg

Product of Canada
Manufactured by: Boehringer Ingelheim
*Product image for reference use only.
Select Quantity
Atrovent Inhaler 20mcg
Product of Canada
Manufactured by Boehringer Ingelheim
Select your dosage

Atrovent (Ipratropium Bromide) Product Information

Atrovent Inhaler is the medication your doctor may prescribe you to prevent and control COPD symptoms, and can also be used for asthma attacks. It is classified as an antimuscarinic bronchodilator which help with wheezing and shortness of breath.

Buy Atrovent or Generic Ipratropium Online

Atrovent Inhaler is manufactured by Boehringer Ingelheim.

We offer the 20 mcg strength starting at $36.00 USD price. The generic for Atrovent is called Ipratropium, which we have available in the same dose as the brand, but it is manufactured by a different company. Generic Ipratropium is available at a cost of 22 USD for one inhaler. Both options are available from our licensed pharmacy in the United Kingdom.

Although we do not have a Atrovent coupon at this moment, you can still get a discount by applying our first time order coupons if your order qualifies. Check out our Rx coupon page for more offers.

The usual shipping time is 7-10 business days to USA.

If you have any questions or need further assistance, please call us toll free at 1-855-776-0079 or message us on chat, which is available on our website.

Atrovent Inhaler (Ipratropium) Medication Information

Uses

Atrovent HFA is an anticholinergic indicated for the maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema

Dosage

Atrovent Inhaler is available in one strength and each actuation of Atrovent HFA delivers 21 mcg of ipratropium bromide from the valve and 17 mcg from the mouthpiece.

Side Effects

The most common side effects of Atrovent include:

  • Bronchitis
  • COPD exacerbation
  • Dyspnea
  • Headache 

Speak with your doctor or pharmacist for a full list of side effects that applies to you.

Precautions

Not indicated for the initial treatment of acute episodes of bronchospasm where rescue therapy is required for rapid response.

Hypersensitivity reactions including anaphylaxis: Discontinue Atrovent HFA at once and consider alternative treatments.

Paradoxical bronchospasm: Discontinue Atrovent HFA and consider other treatments if paradoxical bronchospasm occurs.

Ocular effects: Use with caution in patients with narrow-angle glaucoma and instruct patients to consult a physician immediately if signs or symptoms of narrow-angle glaucoma develop.

Urinary retention: Use with caution in patients with prostatic hyperplasia or bladder-neck obstruction and instruct patients to consult a physician immediately if signs or symptoms of urinary retention develop.

Interactions

Some of the common drug interactions with Atrovent:

  • Anticholinergics

For a more complete list speak with your doctor or pharmacist 

Storage

Store at controlled room temperature (77ºF) and for optimal results the canister should be at room temperature before use. 

Pharmacist Tips

  • Do not puncture canister and do not store near heat or open flame
  • Atrovent should last 2-4 hours
  • Do not increase the dose or frequency of Atrovent without consulting a physician
  • Seek immediate medical attention if treatment with Atrovent HFA becomes less effective for symptomatic relief, symptoms become worse, and/or you need to use the product more frequently than usual.
  • The usual starting dose of Atrovent HFA is two inhalations four times a day. Patients may take additional inhalations as required; however, the total number of inhalations should not exceed 12 in 24 hours.

Atrovent FAQs

How do I use this inhaler?

Atrovent HFA is a solution aerosol that does not require shaking. However, as with any other metered-dose inhaler, some coordination is required between actuating the canister and inhaling the medication.

Patients should "prime" or actuate Atrovent HFA before using for the first time by releasing 2 test sprays into the air away from the face. In cases where the inhaler has not been used for more than 3 days, prime the inhaler again by releasing 2 test sprays into the air away from the face. Patients should avoid spraying Atrovent HFA into their eyes.

 

Can I take this if I am pregnant?

There are no adequate and well-controlled studies of Atrovent HFA (ipratropium bromide) Inhalation Aerosol in pregnant women. Atrovent HFA should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

 

Can I take this while breastfeeding?

It is not known whether the active component, ipratropium bromide, is excreted in human milk. Because lipid-insoluble quaternary cations pass into breast milk, caution should be exercised when Atrovent HFA is administered to a nursing mother.

 

Do I have to shake Atrovent before use?

You do not have to shake Atrovent HFA before using it.

 

When should I get a new inhaler?

The indicator will stop moving at “0”. Discard the inhaler once the dose indicator displays “0”. Even though the canister may not be empty, you cannot be sure of the amount of medicine in each actuation (spray) once the dose indicator displays “0”.

 

What is Atrovent used for?

This medication is used for the treatment of COPD.

 

Related Drugs

Reference:

Atrovent Inhaler {package insert}. Ridgefield, CT: Boehringer Ingelheim Pharmaceuticals, Inc.; 2012.

https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/021527s021lbl.pdf

PharmD Medical Writer

Author: Dr. Larisa Roybal, PharmD

Dr. Roybal is a board-certified pharmacotherapy specialist who has practiced in both ambulatory and acute care settings. Her pharmacy interests include oncology and general inpatient pharmacy.

The above information is an educational aid only. It is not intended as medical advice for individual conditions or treatments. Talk to your doctor, nurse or pharmacist before following any medical regimen to see if it is safe and effective for you.

Back to top